Company Prelude Therapeutics Incorporated
Equities
PRLD
US74065P1012
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.925 USD | -0.13% | -0.76% | -7.96% |
Business Summary
Number of employees: 128
Managers
Managers | Title | Age | Since |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 01/16/01 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 01/23/01 |
Jane Huang
PSD | President | 51 | 04/22/04 |
Wan-Jen Hong
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Madhu Pudipeddi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aimee Crombie
COO | Chief Operating Officer | - | 01/18/01 |
Peggy Scherle
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/18/01 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Michele Porreca
HRO | Human Resources Officer | - | 01/21/01 |
Andrew Combs
PRN | Corporate Officer/Principal | 58 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 25/21/25 |
Paul Friedman
CHM | Chairman | 81 | 01/16/01 |
David Bonita
BRD | Director/Board Member | 48 | 01/16/01 |
Mardi Dier
BRD | Director/Board Member | 60 | 01/20/01 |
Martin Babler
BRD | Director/Board Member | 59 | 19/21/19 |
Victor Sandor
BRD | Director/Board Member | 57 | 01/20/01 |
Krishna Vaddi
FOU | Founder | 58 | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,079,308 | 38,262,046 ( 90.93 %) | 0 | 90.93 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.96% | 216M | |
+36.09% | 52.85B | |
-7.49% | 38.87B | |
+35.31% | 38.24B | |
-10.77% | 26.79B | |
+11.68% | 26.16B | |
-18.08% | 19.9B | |
+36.22% | 13.18B | |
+28.99% | 12.24B | |
-2.95% | 11.79B |
- Stock Market
- Equities
- PRLD Stock
- Company Prelude Therapeutics Incorporated